Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
MWN-AI** Summary
Cosmos Health Inc. (NASDAQ:COSM) recently showcased its expanding brand portfolio at the World Health Expo Dubai 2026, a significant event for the global healthcare industry. Held from February 9–12, the expo welcomed over 235,000 visitors and featured around 4,300 exhibitors from 180 countries. Cosmos Health took this opportunity to exhibit its flagship nutraceutical line, Sky Premium Life®, which has seen robust growth through international distribution agreements and product introductions, particularly in Europe, the Middle East, and North America.
Among its featured products were C-Scrub®, an antiseptic hand and skin wash, and Mediterranation®, a luxury nutritional supplement line infused with organic herbs native to Greece and the Mediterranean. The company emphasized its vertically integrated manufacturing capabilities, facilitated by its subsidiary, Cana Laboratories S.A., which operates under strict European Good Manufacturing Practices (GMP) and is certified by the European Medicines Agency (EMA).
CEO Greg Siokas highlighted the expo's role in fostering strategic relationships and expanding distribution opportunities, noting productive discussions with potential partners from countries as diverse as Japan, China, and various Latin American nations. With ongoing plans for disciplined growth and brand development, Cosmos Health is well-positioned to create long-term value.
Cosmos Health has a diverse portfolio that includes several proprietary pharmaceutical and nutraceutical brands, emphasizing research and development across major health concerns. The company has also ventured into the telehealth space through its acquisition of ZipDoctor, Inc.
As Cosmos Health continues to leverage its international presence and manufacturing capabilities, it remains committed to enhancing its global reach and improving health outcomes through its innovative products. For further information, visit their websites or social media platforms.
MWN-AI** Analysis
As Cosmos Health Inc. (NASDAQ:COSM) makes significant strides in expanding its brand portfolio, investor sentiment may shift positively due to its participation at the World Health Expo Dubai 2026, which demonstrates the company's commitment to international market growth. The Expo's scale, featuring more than 4,300 exhibitors and 235,000 visitors, presents a unique platform for networking and establishing strategic partnerships that could enhance Cosmos Health’s market penetration.
Key highlights from the event include the focus on Cosmos Health’s flagship line, Sky Premium Life®, which is gaining traction globally, particularly in Europe and the Middle East. The company's strategy of leveraging U.S.-based manufacturing to support new product launches in the North American market is a strategic move that may bolster investor confidence as it diversifies revenue streams.
Investors should take note of Cosmos Health's emphasis on fostering relationships in new markets, particularly in Asia and Latin America, where healthcare demand is burgeoning. The CEO's optimistic outlook regarding potential agreements suggests that the company is positioned for disciplined growth and brand development, which are crucial for long-term value creation.
Moreover, the introduction of innovative products, such as C-Scrub® and the Mediterranation® line, enhances the company's portfolio and caters to the rising consumer demand for health and wellness products. Cosmos Health's vertical integration and its manufacturing capabilities certified under European Good Manufacturing Practices position it well against competitors.
While the company remains exposed to market risks and uncertainties—including the impact of ongoing geopolitical events and the economic environment—those considering investment in COSM should weigh the potential for growth driven by strategic partnerships and an expanding product portfolio. As the health and wellness market continues to evolve, Cosmos Health’s proactive approach could translate into sustained shareholder value.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CHICAGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced its participation in World Health Expo Dubai 2026 (formerly Arab Health), one of the world’s largest and most influential healthcare exhibitions and conferences.
The Expo was held February 9–12, 2026, at the Dubai Exhibition Centre in Expo City Dubai, United Arab Emirates, where Cosmos Health exhibited at Booth SA.A79.
The event, which accommodates more than 235,000 visitors and over 4,300 exhibitors from more than 180 countries, brings together healthcare leaders, distributors, manufacturers, and innovators to explore emerging trends, foster strategic partnerships, and advance international collaboration within the healthcare sector.
At the exhibition, Cosmos Health showcased its growing portfolio of proprietary nutraceutical and wellness brands, led by its flagship Sky Premium Life® line of nutraceuticals, which continues to gain global traction through expanded distribution agreements, new product introductions, and increasing international demand. The brand’s premium formulations have strengthened its presence across the key markets in Europe and the Middle East, while its recent expansion into the North American market through the NOOR line is supported by Cosmos Health’s U.S.-based manufacturing capabilities.
The Company also highlighted several of its other healthcare and consumer brands, including C-Scrub®, its antiseptic wash formulated to deliver reliable antimicrobial properties and support effective hand and skin hygiene, as well as Mediterranation®, its proprietary luxury nutritional supplement line featuring formulations that incorporate organic herbs and plant extracts traditionally sourced from Greece and the broader Mediterranean region, including crataegus, hibiscus, dittany of Crete, oregano, mastic, and kritamos.
The Company’s presence at the Expo provided an opportunity to raise awareness of its vertically integrated manufacturing capabilities and to engage with potential commercial partners, distributors, and industry stakeholders.
Greg Siokas, CEO of Cosmos Health, stated: “Participating in World Health Expo Dubai underscores our commitment to expanding the global footprint of our proprietary brands. Sky Premium Life continues to gain international momentum, and this platform enables us to strengthen strategic relationships, expand distribution opportunities, and showcase the depth and quality of our portfolio. During the exhibition, we held highly productive meetings with participating parties from new regions and territories, ranging from Japan and China to several Latin American countries, and we are currently in the process of advancing several potential agreements. We remain focused on disciplined growth, brand development, and long-term value creation.”
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of any new information, future events, or otherwise.
Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com
A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/94a84d85-d3b0-4fc8-90ce-e6d6e573c9f1
Disclaimer
This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a COSM financial position. COSM financial position and all other information regarding the featured Company should be verified directly with COSM. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in COSM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of COSM shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Compensation: Market Wire News and its affiliates has received six thousand dollars for Market Wire News advertising services from Relqo Media LLC for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting 2026-05-31 and ending 2026-06-05 provided by Market Wire News. To date, we have received a total of six thousand dollars. Please read our full disclaimer for compensation and more detailed information.
FAQ**
How does Cosmos Holdings Inc. (COSM) plan to leverage its participation in World Health Expo Dubai 2026 to enhance the global reach of its proprietary brands like Sky Premium Life and Mediterranation?
What specific strategies is Cosmos Holdings Inc. (COSM) implementing to foster partnerships and collaborations stemming from engagements made during the World Health Expo Dubai 2026?
Can you provide insights on how Cosmos Holdings Inc. (COSM) intends to address risks outlined in its forward-looking statements while expanding its distribution capacity in North America and Asia?
With the rise of strategic relationships cultivated at the World Health Expo Dubai 2026, what are the projected growth areas for Cosmos Holdings Inc. (COSM) in the emerging nutraceutical and healthcare markets?
**MWN-AI FAQ is based on asking OpenAI questions about Cosmos Health Inc. (NASDAQ: COSM).
NASDAQ: COSM
COSM Trading
-3.36% G/L:
$0.2505 Last:
367,675 Volume:
$0.264 Open:
